세계의 바이오의약품 제조용 소모품 검사 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 원재료별, 지역별, 부문 예측(2025-2030년)

Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory Testing, Custom Testing), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,407,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,820,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,646,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

바이오의약품 제조용 소모품 검사 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 바이오의약품 제조용 소모품 검사 시장 규모는 2025년부터 2030년까지 12.4%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 12억 7,000만 달러에 달할 것으로 추정됩니다.

이 시장을 주도하고 있는 것은 최종 제품을 성공적으로 출시하기 위해 원료를 면밀히 평가해야 할 필요성이 증가하고 있다는 점입니다. 바이오 제약 산업의 외부 규제뿐만 아니라 내부 표준에 대한 인식이 높아짐에 따라 시장 성장을 가속하고 있습니다.

최근 몇 년 동안 작은 화학 분자에서 큰 생물학적 분자로의 패러다임 전환이 일어나고 있습니다. 그 결과, 바이오 제약 산업은 제조 공정과 관련된 모든 측면을 탐구하는 방향으로 나아가고 있습니다.

최고 품질의 원료 및 중간체에 대한 규제와 품질에 대한 기대는 지속적으로 증가하고 있습니다. 따라서 부형제 및 원료 제조 업체는 최종 제품 개발자의 요구에 일관되게 대응하기 위해 기능 표준화 및 정교한 프로세스 구축에 투자해야 합니다.

바이오 의약품 제조용 소모품 검사 시장 보고서 하이라이트

• 서비스별로는 컴펜디얼 테스트와 멀티 컴펜디얼 테스트가 가장 큰 비중을 차지하고 있습니다.
• 원료별로는 원료의약품(API) 분야가 가장 큰 매출 비중을 차지했는데, 이는 이 분야에 다양한 서비스가 존재하기 때문입니다.
• 미국에는 다수의 생물학적 제제 제조 기업이 존재하기 때문에 2024년에는 북미가 세계 시장을 독점했습니다. 경쟁 기업 간의 적대적 관계 증가도 이 지역의 큰 점유율을 차지하는 요인으로 작용하고 있습니다.
• 아시아태평양은 예측 기간 동안 높은 CAGR로 성장할 것으로 예상되며, 그 주요 요인은 아시아 국가들의 위탁 서비스 산업이 확대되고 있기 때문입니다. 이는 이들 국가의 낮은 운영 비용에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 바이오의약품 제조용 소모품 검사 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTLE 분석

제4장 바이오의약품 제조용 소모품 검사 시장 : 서비스별 비즈니스 분석

• 서비스별 시장 점유율, 2024년과 2030년
• 서비스별 부문 대시보드
• 서비스별 시장 규모, 예측, 동향 분석(2018-2030년)
• 임상 검사
• 커스텀 테스트/고객의 독자적인 검사
• 공정서 및 멀티 공정서에 근거한 레버러토리 검사

제5장 바이오의약품 제조용 소모품 검사 시장 : 원재료별 비즈니스 분석

• 원재료별 시장 점유율, 2024년과 2030년
• 원재료별 부문 대시보드
• 원재료별 시장 규모, 예측, 동향 분석(2018-2030년)
• 제제 첨가물
• 의약품 유효 성분(API)
• 공정법(USP/EP/JP)에 근거한 벤더 적격성 평가 프로그램 지원

제6장 바이오의약품 제조용 소모품 검사 시장 : 지역 원재료별 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년까지 :
• 북미
  • 국가별, 2018년-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018년-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 국가별, 2018년-2030년
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 국가별, 2018년-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018년-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 참여 기업 개요
• 기업 시장 현황 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장기업
  • Alcami Corporation
  • Merck KGaA
  • Eurofins Scientific
  • Agilent Technologies, Inc.
  • Charles River Laboratories.
  • Catalent, Inc
  • Element Materials Technology(Avomeen Analytical Services)
  • Pace Analytical Services, LLC
  • Nelson Laboratories, LLC(Gibraltar Laboratories)

LSH

영문 목차

영문목차

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends:

The global biopharmaceuticals manufacturing consumables testing market size is estimated to reach USD 1.27 billion by 2030, registering a CAGR of 12.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights:

• Based on service, compendial and multi-compendial testing held the largest share, owing to demand from various manufacturers for raw materials that are compliant to regulatory standards.
• Based on raw material, the active pharmaceutical ingredients (APIs) segment accounted for the largest revenue share, owing to the presence of a wide range of services in this segment.
• Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2024. Rising competitive rivalry amongst market participants is also attributive for the large share of this region.
• Asia Pacific is expected to grow at a significant CAGR over the forecast period, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Raw Material
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Business Analysis

• 4.1. Service Market Share, 2024 & 2030
• 4.2. Service Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 4.4. Laboratory Testing
  • 4.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
• 4.5. Custom Testing / Customer Proprietary Testing
  • 4.5.1. Custom Testing / Customer Proprietary Testing Market, 2018 - 2030 (USD Million)
• 4.6. Compendial & Multi Compendial Laboratory Testing
  • 4.6.1. Compendial & Multi Compendial Laboratory Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Business Analysis

• 5.1. Raw Material Market Share, 2024 & 2030
• 5.2. Raw Material Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Raw Material, 2018 to 2030 (USD Million)
• 5.4. Formulation Excipients
  • 5.4.1. Formulation Excipients Market, 2018 - 2030 (USD Million)
• 5.5. Active Pharmaceutical Ingredients (API)
  • 5.5.1. Active Pharmaceutical Ingredients (API) Market, 2018 - 2030 (USD Million)
• 5.6. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
  • 5.6.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market, 2018 - 2030 (USD Million)

Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Alcami Corporation
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Merck KGaA
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Eurofins Scientific
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Agilent Technologies, Inc.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Charles River Laboratories.
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Catalent, Inc
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Element Materials Technology (Avomeen Analytical Services)
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Pace Analytical Services, LLC
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives

관련자료